ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
CorMedix Inc

CorMedix Inc (CRMD)

8,90
0,00
(0,00%)
Fermé 08 Février 10:00PM
8,90
0,00
( 0,00% )
Avant marché: 1:00AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
8,90
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
8,90
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
54 812 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-12,02
Bénéfice par action (BPA)
-0,85
Chiffre d'affairess
-
Bénéfice net
-46,34M

À propos de CorMedix Inc

Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the r... Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-

CRMD Dernières nouvelles

CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange

BERKELEY HEIGHTS, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

PDUFA date remains February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients BERKELEY...

CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Appoints Greg Duncan to its Board of Directors

BERKELEY HEIGHTS, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix to Participate in BIO Investor Forum Digital

BERKELEY HEIGHTS, N.J., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Appoints Paulo Costa to its Board of Directors

BERKELEY HEIGHTS, N.J., Sept. 17, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

BERKELEY HEIGHTS, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath

FDA sets PDUFA goal date of February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients ...

CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Announces Pricing of $20M Public Offering of Common Stock

BERKELEY HEIGHTS, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD) (the “Company”), a biopharmaceutical company focused on developing and commercializing therapeutic...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CRMD - Frequently Asked Questions (FAQ)

What is the current CorMedix share price?
The current share price of CorMedix is US$ 8,90
How many CorMedix shares are in issue?
CorMedix has 54 812 000 shares in issue
What is the market cap of CorMedix?
The market capitalisation of CorMedix is USD 487,83M
What is the 1 year trading range for CorMedix share price?
CorMedix has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of CorMedix?
The price to earnings ratio of CorMedix is -12,02
What is the reporting currency for CorMedix?
CorMedix reports financial results in USD
What is the latest annual profit for CorMedix?
The latest annual profit of CorMedix is USD -46,34M
What is the registered address of CorMedix?
The registered address for CorMedix is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the CorMedix website address?
The website address for CorMedix is www.cormedix.com
Which industry sector does CorMedix operate in?
CorMedix operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INLXIntellinetics Inc
US$ 20,62
(59,84%)
3
BHMBluerock Homes Trust Inc
US$ 17,23
(52,48%)
5
EPEmpire Petroleum Corporation
US$ 6,99
(21,57%)
1
GPUSHyperscale Data Inc
US$ 4,20
(14,91%)
3
VINEFresh Vine Wine Inc
US$ 0,836
(12,97%)
100
SVTServotronics Inc
US$ 8,01
(-27,18%)
1
LGLLGL Group Inc
US$ 5,01
(-24,32%)
2
IBOImpact Biomedical Inc
US$ 1,91
(-16,23%)
5
PBPInvesco S&P 500 BuyWrite ETF
US$ 21,01
(-12,17%)
3
AWXAvalon Holdngs Corp
US$ 3,01
(-11,99%)
1
ETHU2x Ether ETF
US$ 4,31
(5,12%)
863,72k
FXIiShares China Large Cap
US$ 33,485
(2,31%)
708,23k
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 26,75
(1,60%)
665,47k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,92
(2,64%)
570,67k
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 9,06
(3,54%)
415,17k
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock